Statins reduce mortality in sepsis
Statin therapy reduces the risk of death significantly for patients with sepsis, researchers reported on June 6, 2025 in Frontiers in Immunology. As background, the authors noted that… read more.
Statin therapy reduces the risk of death significantly for patients with sepsis, researchers reported on June 6, 2025 in Frontiers in Immunology. As background, the authors noted that… read more.
Breast cancer detected by routine screening of women aged 40 years or older is associated with lower odds of advanced cancer, mastectomy, and breast cancer–related death compared with… read more.
Among patients with ongoing, uncontrolled hypertension in spite of treatment with indapamide, amlodipine, or olmesartan, the addition of a single dose of investigative zilebesiran has, at 3 months,… read more.
Antidepressants that suppress REM (rapid eye movement) sleep appear to improve survival in people with amyotrophic lateral sclerosis (ALS). Researchers reported the finding on May 21, 2025 at… read more.
While prednisone is the standard first-line treatment for pulmonary sarcoidosis, side effects can diminish quality of life. Researchers report that methotrexate appears to have fewer side effects and… read more.
Results from a large South Korean study suggests that persons who are vaccinated to prevent shingles have a 23% lower risk of developing cardiovascular events, including stroke, heart… read more.
Metabolic syndrome appears to be linked to onset of dementia before age 65, also known as young-onset dementia. Researchers reported the findings on April 23, 2025 in Neurology…. read more.
Hydroxyurea therapy, a standard treatment for children with sickle cell disease (SCD), remains effective over the long term for reducing emergency department visits and hospital days among pediatric… read more.
Heart attack/myocardial infarction (MI) patients treated early with cholesterol-lowering ezetimibe and a statin have achieved a significantly better prognosis than those who received ezetimibe later or not all…. read more.
Results from a Phase 3 study of treatment with investigational tolebrutinib show a 31% delay in the onset of six-month confirmed disability progression (CDP) in patients with non-relapsing… read more.
The use of cannabidiol (CBD) cannabis extract shows efficacy in the treatment of autism spectrum disorder (ASD) in children and adolescents, researchers report. The findings from a new… read more.
Compared with people with elevated levels of low-density lipoprotein cholesterol (LDL-C), researchers report that people with lower levels of LDL-C have a relatively lower risk of developing dementia…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.